South Korea-based Celltrion, Inc. has announced that the US Food and Drug Administration (FDA) has approved an expanded ...
India-based Intas Pharmaceuticals, in collaboration with its global subsidiaries operating under the Accord brand, has s...
Everest Medicines, a China-based biopharmaceutical company focused on the discovery, clinical development, manufacturing...
Arrowhead Pharmaceuticals, Inc. has announced the signing of an asset purchase agreement between Sanofi and Visirna Ther...
Viridian Therapeutics, Inc., a US-based biopharmaceutical company focused on discovering, developing, and commercialisin...
Dr. Falk Pharma GmbH, a Germany-headquartered research-based pharmaceutical company specialising in digestive and metabo...
Asahi Kasei Life Science, a division of diversified global manufacturer Asahi Kasei, has announced plans to construct a ...
The pharmaceutical and life sciences industry has been undergoing a transformation driven by rapid technological change,...
What are your plans for capacity expansion in biologics and ADC manufacturing? We are already among the largest biologi...
Presently, what are HSA’s key priorities that align with positioning Singapore as a regional hub for biotech and m...
Australian biotech is known for its cutting-edge research, robust clinical trial activity, and favourable R&D infras...
Global interest in radiopharmaceuticals has surged in recent years, driven by a string of high-profile deals and rising ...
GSK plc has entered into agreements with China-based Hengrui Pharma to develop up to 12 innovative medicines, adding sig...
Colorcon, a global leader of film coating systems, specialty excipients, controlled release formulations and controlled ...
India's Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has laun...
MilliporeSigma, the US and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technol...
Bora Health, subsidiary of SunWay Biotech which focuses on pharmaceutical distribution and sales in Taiwan, has entered ...
Japan-based Eisai Co. and Kyorin Pharmaceutical Co. have announced that Eisai (Thailand) Marketing Co., a subsidiary of ...
Cenra Healthcare, the sales and marketing arm of Cenra Inc., has announced the deepening of its long-standing collaborat...
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that f...
AstraZeneca has announced $50 billion of investment in the United States by 2030, building on America’s global lea...
China's Sino Biopharm has announced the completion of a binding Sale and Purchase Agreement to acquire LaNova Medicines....
CorestemChemon, a leading GLP-certified preclinical CRO based in South Korea, has entered into a strategic partners...
Hyphens Pharma, a subsidiary of Hyphens Pharma International Limited, Singapore’s leading specialty pharmaceutical...
Japan-based Astellas Pharma Inc. has agreed on a Memorandum of Understanding (MoU) with the Korea Institute of Star...
